## NPCDCS Cervical Cancer Screening Protocol **Key Point:** Visual Inspection with Acetic Acid (VIA) is the WHO-recommended and NPCDCS-endorsed screening test for primary health centers in resource-limited settings like India. ### Rationale for VIA at PHC Level **High-Yield:** VIA is preferred because it is: - **Low-cost** (minimal infrastructure required) - **Real-time results** (no need for laboratory processing) - **High sensitivity and specificity** (85–92% and 85–90% respectively) - **Feasible** in peripheral health centers with minimal training ### Comparison of Cervical Cancer Screening Methods | Method | Setting | Cost | Sensitivity | Specificity | Infrastructure | |--------|---------|------|-------------|-------------|----------------| | VIA | PHC/CHC | Low | 85–92% | 85–90% | Minimal | | Pap smear | CHC/District | Moderate | 60–70% | 95% | Lab required | | HPV DNA | Tertiary | High | 95%+ | 90%+ | Advanced lab | | Colposcopy | Tertiary | High | Variable | Variable | Specialized | **Clinical Pearl:** NPCDCS guidelines recommend a "see-and-treat" approach using VIA at the PHC level, where women with positive VIA are referred for colposcopy and treatment at higher centers, improving accessibility and reducing loss to follow-up. **Mnemonic:** **VIA-PHC** = Visual Inspection with Acetic acid at Primary Health Center (the screening backbone of NPCDCS cervical cancer program). [cite:Park 26e Ch 9]
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.